DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Moore M, Hamm J, Eisenberg P. et al.
A comparison between gemcitabine (GEM) and the matrix metalloproteinase (MMP) inhibitor BAY12 - 9566 (9566) in patients (PTS) with advanced pancreatic cancer [ASCO Abstract].
Proc Am Soc Clin Oncol 2000; 19: 240 a (Abstr 930)-
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.